FNDC3B and pachyonychia congenita: Then subgroup analyses demonstrated that within the subgroups of PC patients without radiation therapy, male gender, white race, age ≤ 65 years old, histologic grade G1, or other anatomic neoplasm subdivisions, those with high FNDC3B expression had poorer OS outcomes (Fig. 5D–I, P < 0.05).